|
JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS (Details Textual) (USD $)
|
0 Months Ended |
9 Months Ended |
26 Months Ended |
|
Aug. 03, 2012
|
Sep. 30, 2014
|
Sep. 30, 2014
|
| Related Party Transaction [Line Items] |
|
|
|
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures |
$ 6,000,000 |
$ 6,000,000 |
$ 6,000,000 |
| Joint Venture Investments In Voting Common Ownership Units (in shares) |
600,000 |
|
|
| Joint Venture Method Investment Ownership Percentage |
60.00% |
|
|
| Joint Venture Investments In Non Voting Preferred Ownership Units |
5,000,000 |
|
|
| Payments to Acquire Long-term Investments |
3,300,000 |
|
|
| Joint Venture Investments Common Ownership Units, Coventure (in shares) |
400,000 |
|
|
| Ownership Percentage Coventure |
40.00% |
|
|
| Percentage Of Royalty Payment |
3.00% |
|
|
| Development Activities Monthly Fee |
63,000 |
|
|
| Accounting and Administrative Monthly Fee |
1,000 |
|
|
| Joint Venture, Operating Expenses, Inter Company Transactions |
|
2,226,000 |
6,076,000 |
| Joint Venture, Operating Expenses Allocated To Company |
|
2,226,000 |
5,409,000 |
| Percentage Of Non Royalty Income |
15.00% |
|
|
| Reduced Monthly Management Fee |
35,000 |
|
|
|
Revolving Credit Facility [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Line of Credit Facility, Maximum Borrowing Capacity |
|
500,000 |
500,000 |
|
Common Stock [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Joint Venture Losses Recognition Criteria, Common Ownership Equity |
|
0 |
0 |
| Noncontrolling Interest, Ownership Percentage by Parent |
|
60.00% |
60.00% |
| Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners |
|
40.00% |
40.00% |
|
Preferred Stock [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Noncontrolling Interest, Ownership Percentage by Parent |
|
100.00% |
100.00% |
|
Exclusive License Agreement [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Annual Maintenance Payments |
25,000 |
|
|
|
Exclusive License Agreement [Member] | Maximum [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Milestone Payments |
1,000,000 |
|
|
| Royalty Expense |
5,000,000 |
|
|
|
Exclusive License Agreement [Member] | Minimum [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Milestone Payments |
50,000 |
|
|
| Royalty Expense |
1,000,000 |
|
|
|
Corporate Joint Venture [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Investments In and Advance To Affiliates Additional Performance Measured Incentive Fee |
2,700,000 |
|
|
|
Voting Common Ownership Units [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures |
1,000,000 |
|
|
|
Non Voting Preferred Ownership Units [Member]
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures |
$ 5,000,000 |
|
|